Recommendations for the development and validation of flow cytometry-based receptor occupancy assays-Reference-Cited by-同舟云学术

Recommendations for the development and validation of flow cytometry-based receptor occupancy assays

Published:2016-02-22 Issue:2 Volume:90 Page:141-149
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Green Cherie L.¹,Stewart Jennifer J.²,Högerkorp Carl-Magnus³,Lackey Alan⁴,Jones Nicholas⁴,Liang Meina⁵,Xu Yuanxin⁶,Ferbas John¹,Moulard Maxime⁷,Czechowska Kamila⁸,Mc Closkey Thomas W.⁹,van der Strate Barry W.A.¹⁰,Wilkins Danice E.C.¹¹,Lanham David¹²,Wyant Timothy¹³,Litwin Virginia¹⁴

Affiliation:

1. Amgen, Inc; 1 Amgen Center Drive, Mailstop 30E-3-C Thousand Oaks California 91320

2. Flow Contract Site Laboratory, LLC; 13029 NE 126th PL, Unit A229 Kirkland Washington 98034

3. Novo Nordisk a/S; Novo Nordisk Park Måløv DK 2760 Denmark

4. Laboratory Corporation of America® Holdings; LabCorp Clinical Trials; 201 Summit View Dr, Suite 200 Brentwood Tennessee 37027

5. Medimmune, LLC; 319 North Bernardo Avenue Mountain View California 94043

6. Alnylam Pharmaceuticals; Bioanalytical Sciences; 300 Third Street Cambridge Massachusetts 02142

7. BioCytex; 140 Chemin De L'armée D'afrique Marseille 13010 France

8. 7 Rue Moïse-Marcinhes; Geneva Meyrin 1217 Switzerland

9. ICON Laboratory Services; 123 Smith Street Farmingdale New York 11735

10. PRA Healthsciences; Amerikaweg 18 Assen TK 9407 The Netherlands

11. Charles River Laboratories International, Inc; 6995 Longley Lane Reno Nevada 89511

12. Eurofins Pharma Bioanalysis Services UK Limited; 91 Park Drive Milton Park Abingdon OX14 4RY United Kingdom

13. Takeda Pharmaceuticals; 35 Landsdown St Cambridge Massachusetts 02139

14. Covance Central Laboratory Services; 8211 SciCor Dr Indianapolis Indiana 46214

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference44 articles.

1. Pharmacokinetic/pharmacodynamic studies in drug product development;Meibohm;J Pharm Sci,2002

2. Stewart JJ Green CL Jones N Liang M Xu Y Litwin V Wilkins D Moulard M Czechowska K Lanham D

3. Flow cytometer performance characterization, standardization and calibration against CD4 on T lymphocytes enables quantification of biomarker expressions for immunological applications;Degheidy;J Biomed Sci Eng,2014

4. A quantitative flow cytometric assay for determining binding characteristics of chimeric, humanized and human antibodies in whole blood: proof of principle with rituximab and ofatumumab;Engelberts;J Immunol Methods,2013

5. Formalization of the MESF unit of fluorescence intensity;Schwartz;Cytometry B Clin Cytom,2004

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor activity of QL1604, a humanized anti–PD-1 mAb, in patients with advanced or metastatic solid tumors;Frontiers in Immunology;2023-10-23

2. A Bispecific Peptide‐Polymer Conjugate Bridging Target‐Effector Cells to Enhance Immunotherapy;Advanced Healthcare Materials;2023-03-17

3. Recent Progress in Biomarker Bioanalysis and Target Engagement Assessment;Bioanalytical Aspects in Biological Therapeutics;2022-07

4. Special Techniques in Toxicologic Pathology;Haschek and Rousseaux's Handbook of Toxicologic Pathology;2022

5. The Evolution of Single-Cell Analysis and Utility in Drug Development;The AAPS Journal;2021-08-13